These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18521090)

  • 1. Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.
    Lavedan C; Licamele L; Volpi S; Hamilton J; Heaton C; Mack K; Lannan R; Thompson A; Wolfgang CD; Polymeropoulos MH
    Mol Psychiatry; 2009 Aug; 14(8):804-19. PubMed ID: 18521090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
    Thompson A; Lavedan C; Volpi S
    Psychiatry Res; 2010 Feb; 175(3):271-3. PubMed ID: 20045196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
    J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients.
    Wei Z; Wang L; Xuan J; Che R; Du J; Qin S; Xing Y; Gu B; Yang L; Li H; Li J; Feng G; He L; Xing Q
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):547-51. PubMed ID: 19233240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
    Potkin SG; Litman RE; Torres R; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
    Volpi S; Potkin SG; Malhotra AK; Licamele L; Lavedan C
    J Clin Psychiatry; 2009 Jun; 70(6):801-9. PubMed ID: 19573479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.
    Volpi S; Heaton C; Mack K; Hamilton JB; Lannan R; Wolfgang CD; Licamele L; Polymeropoulos MH; Lavedan C
    Mol Psychiatry; 2009 Nov; 14(11):1024-31. PubMed ID: 18521091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial.
    Lavedan C; Volpi S; Polymeropoulos MH; Wolfgang CD
    Pharmacogenomics; 2008 Mar; 9(3):289-301. PubMed ID: 18303965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iloperidone for schizophrenia.
    Rado J; Janicak PG
    Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iloperidone: a new option for the treatment of schizophrenia.
    Cutler AJ
    Expert Rev Neurother; 2009 Dec; 9(12):1727-41. PubMed ID: 19951132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.
    Fijal BA; Stauffer VL; Kinon BJ; Conley RR; Hoffmann VP; Witte MM; Zhao F; Houston JP
    J Clin Psychiatry; 2012 Mar; 73(3):367-71. PubMed ID: 21813073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.
    Crisafulli C; Chiesa A; De Ronchi D; Han C; Lee SJ; Park MH; Patkar AA; Pae CU; Serretti A
    Neurosci Lett; 2012 Jan; 506(1):170-4. PubMed ID: 22094384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
    Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
    Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloperidone for the management of adults with schizophrenia.
    Crabtree BL; Montgomery J
    Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia.
    Mössner R; Schuhmacher A; Kühn KU; Cvetanovska G; Rujescu D; Zill P; Quednow BB; Rietschel M; Wölwer W; Gaebel W; Wagner M; Maier W
    Pharmacogenet Genomics; 2009 Jan; 19(1):91-4. PubMed ID: 18849890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based gene selection shows engrailed 1 is associated with antipsychotic response.
    Webb BT; Sullivan PF; Skelly T; van den Oord EJ
    Pharmacogenet Genomics; 2008 Sep; 18(9):751-9. PubMed ID: 18698228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.
    Citrome L
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.
    Greenbaum L; Strous RD; Kanyas K; Merbl Y; Horowitz A; Karni O; Katz E; Kotler M; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenet Genomics; 2007 Jul; 17(7):519-28. PubMed ID: 17558307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.